| KEGG pathway | Number of targets | Count |
| Pathways in cancer | IL6, AR, PTGS2, PDGFA, MMP9, PPARG, TP53, MMP2, TGFB1, MMP1, STAT3, AGTR1, HIF1A, VEGFA, F2R | 15 | Neuroactive ligand-receptor interaction | AGTR1, ADRB2, DRD2, CHRM2, LEPR, F2, ADRA1A, NR3C1, HTR2C, F2R, HTR2A | 11 | Proteoglycans in cancer | HIF1A, TNF, MMP9, VEGFA, ESR1, TP53, MMP2, TGFB1, STAT3 | 9 | PI3K-Akt signaling pathway | IL4, IL6, PDGFA, CHRM2, VEGFA, TP53, NOS3, JAK3, F2R | 9 | Malaria | VCAM1, ICAM1, SELP, IL6, TNF, IFNG, TGFB1, IL10 | 8 | Calcium signaling pathway | AGTR1, ADRB2, CHRM2, ADRA1A, NOS3, HTR2C, F2R, HTR2A | 8 | HTLV-I infection | VCAM1, ICAM1, IL6, TNF, PDGFA, TP53, JAK3, TGFB1 | 8 | Inflammatory bowel disease (IBD) | IL4, IL6, TNF, IFNG, TGFB1, IL10, STAT3 | 7 | Rheumatoid arthritis | ICAM1, IL6, TNF, IFNG, VEGFA, TGFB1, MMP1 | 7 | HIF-1 signaling pathway | IL6, HIF1A, IFNG, EDN1, VEGFA, NOS3, STAT3 | 7 | TNF signaling pathway | VCAM1, ICAM1, IL6, TNF, PTGS2, MMP9, EDN1 | 7 | Jak-STAT signaling pathway | IL4, IL6, LEPR, IFNG, JAK3, IL10, STAT3 | 7 | Cytokine-cytokine receptor interaction | IL4, IL6, TNF, LEPR, IFNG, TGFB1, IL10 | 7 | African trypanosomiasis | VCAM1, ICAM1, IL6, TNF, IFNG, IL10 | 6 | Leishmaniasis | IL4, TNF, PTGS2, IFNG, TGFB1, IL10 | 6 |
|
|